Comparison 22. Tocolytic (nifedipine) vs tocolytic (terbutaline) ‐ nullips vs multips.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Cephalic presentation at birth (primary)	0	0	Risk Ratio (M‐H, Random, 95% CI)	0.0 [0.0, 0.0]
1.1 Nullips	0	0	Risk Ratio (M‐H, Random, 95% CI)	0.0 [0.0, 0.0]
1.2 Multips	0	0	Risk Ratio (M‐H, Random, 95% CI)	0.0 [0.0, 0.0]
2 Caesarean section (primary)	0	0	Risk Ratio (M‐H, Random, 95% CI)	0.0 [0.0, 0.0]
2.1 Nullips	0	0	Risk Ratio (M‐H, Random, 95% CI)	0.0 [0.0, 0.0]
2.2 Multips	0	0	Risk Ratio (M‐H, Random, 95% CI)	0.0 [0.0, 0.0]
3 Fetal bradycardia (primary)	0	0	Risk Ratio (M‐H, Random, 95% CI)	0.0 [0.0, 0.0]
3.1 Nullips	0	0	Risk Ratio (M‐H, Random, 95% CI)	0.0 [0.0, 0.0]
3.2 Multips	0	0	Risk Ratio (M‐H, Random, 95% CI)	0.0 [0.0, 0.0]
4 Failed ECV	1	86	Risk Ratio (M‐H, Random, 95% CI)	1.38 [0.90, 2.13]
4.1 Nullips	1	39	Risk Ratio (M‐H, Random, 95% CI)	1.60 [0.83, 3.10]
4.2 Multips	1	47	Risk Ratio (M‐H, Random, 95% CI)	1.23 [0.69, 2.19]
4.3 Caesarean section (primary)	0	0	Risk Ratio (M‐H, Random, 95% CI)	0.0 [0.0, 0.0]